A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2008-2017

ABSTRACT

This study will compare progression-free survival in patients with advanced non-squamous non-small cell lung cancer. Patients who do not progress following 4 cycles of induction treatment with pemetrexed and cisplatin will be randomized 2:1 to receive either maintenance pemetrexed or placebo.

URL

https://clinicaltrials.gov/show/NCT00789373

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "This study will compare progression-free survival in patients with advanced non-squamous non-small cell lung cancer. Patients who do not progress following 4 cycles of induction treatment with pemetrexed and cisplatin will be randomized 2:1 to receive either maintenance pemetrexed or placebo.", 
    "endDate": "2017-11-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00789373", 
    "keywords": [
      "phase 3", 
      "Double-Blind", 
      "BEST", 
      "supportive care", 
      "induction", 
      "cisplatin", 
      "non small cell lung cancer", 
      "Disease-Free Survival", 
      "patient", 
      "progress", 
      "cycle", 
      "placebo"
    ], 
    "name": "A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction Treatment With Pemetrexed + Cisplatin for Advanced Non-squamous Non-Small Cell Lung Cancer.", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00789373"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00006.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.421033.7", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.417540.3", 
        "type": "Organization"
      }
    ], 
    "startDate": "2008-11-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1016/j.clinthera.2012.12.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008108025"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(12)70063-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012995827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0000000000000076", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026521756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2012.47.1102", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041282863"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-10-85", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042610873", 
          "https://doi.org/10.1186/1471-2407-10-85"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cllc.2014.06.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046482380"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0b013e318267cf84", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047006729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/03007995.2018.1439462", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100924396"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00789373"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00789373'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00789373'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00789373'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00789373'


 

This table displays all metadata directly associated to this object as RDF triples.

58 TRIPLES      16 PREDICATES      36 URIs      21 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00789373 schema:about anzsrc-for:3142
2 schema:description This study will compare progression-free survival in patients with advanced non-squamous non-small cell lung cancer. Patients who do not progress following 4 cycles of induction treatment with pemetrexed and cisplatin will be randomized 2:1 to receive either maintenance pemetrexed or placebo.
3 schema:endDate 2017-11-01T00:00:00Z
4 schema:keywords BEST
5 Disease-Free Survival
6 Double-Blind
7 cisplatin
8 cycle
9 induction
10 non small cell lung cancer
11 patient
12 phase 3
13 placebo
14 progress
15 supportive care
16 schema:name A Phase 3, Double-Blind, Placebo-Controlled Study of Maintenance Pemetrexed Plus Best Supportive Care Versus Best Supportive Care Immediately Following Induction Treatment With Pemetrexed + Cisplatin for Advanced Non-squamous Non-Small Cell Lung Cancer.
17 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00789373
18 schema:sdDatePublished 2019-03-07T15:23
19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
20 schema:sdPublisher N1bbfc43904aa428cbadeebab21cabdb2
21 schema:sponsor https://www.grid.ac/institutes/grid.417540.3
22 https://www.grid.ac/institutes/grid.421033.7
23 schema:startDate 2008-11-01T00:00:00Z
24 schema:subjectOf sg:pub.10.1186/1471-2407-10-85
25 https://doi.org/10.1016/j.clinthera.2012.12.013
26 https://doi.org/10.1016/j.cllc.2014.06.007
27 https://doi.org/10.1016/s1470-2045(12)70063-3
28 https://doi.org/10.1080/03007995.2018.1439462
29 https://doi.org/10.1097/jto.0000000000000076
30 https://doi.org/10.1097/jto.0b013e318267cf84
31 https://doi.org/10.1200/jco.2012.47.1102
32 schema:url https://clinicaltrials.gov/show/NCT00789373
33 sgo:license sg:explorer/license/
34 sgo:sdDataset clinical_trials
35 rdf:type schema:MedicalStudy
36 N1bbfc43904aa428cbadeebab21cabdb2 schema:name Springer Nature - SN SciGraph project
37 rdf:type schema:Organization
38 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
39 rdf:type schema:DefinedTerm
40 sg:pub.10.1186/1471-2407-10-85 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042610873
41 https://doi.org/10.1186/1471-2407-10-85
42 rdf:type schema:CreativeWork
43 https://doi.org/10.1016/j.clinthera.2012.12.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008108025
44 rdf:type schema:CreativeWork
45 https://doi.org/10.1016/j.cllc.2014.06.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046482380
46 rdf:type schema:CreativeWork
47 https://doi.org/10.1016/s1470-2045(12)70063-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012995827
48 rdf:type schema:CreativeWork
49 https://doi.org/10.1080/03007995.2018.1439462 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100924396
50 rdf:type schema:CreativeWork
51 https://doi.org/10.1097/jto.0000000000000076 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026521756
52 rdf:type schema:CreativeWork
53 https://doi.org/10.1097/jto.0b013e318267cf84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047006729
54 rdf:type schema:CreativeWork
55 https://doi.org/10.1200/jco.2012.47.1102 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041282863
56 rdf:type schema:CreativeWork
57 https://www.grid.ac/institutes/grid.417540.3 schema:Organization
58 https://www.grid.ac/institutes/grid.421033.7 schema:Organization
 




Preview window. Press ESC to close (or click here)


...